Pacira Pharmaceuticals, Inc. · Parsippany, NJ United States (NASDAQ: PCRX)
| 5 Sylvan Way, Ste. 125 | Phone: 973-254-3560 |
| Parsippany, NJ | |
| 07054 | |
| United States | 
Map This Company |
Pacira Pharmaceuticals, Inc. Rankings
| Russell 2000 (June 2011) |
More Companies in These Related Industries: Pharmaceutical Preparation MfgCompany Description
Pacira Pharmaceuticals lets injections last longer with its DepoFoam technology. The company develops sustained-release therapies based on DepoFoam, an injectable drug delivery technology that allows both immediate and sustained release. Its two established products are DepoCyt for treating cancer-related neoplastic meningitis and DepoDur for the treatment of post-operative pain. Pacira's newest drug, EXPAREL, is an injectable local anesthetic. The company has two manufacturing facilities that make its Depo products. Pacira went public in early 2011 through an IPO valued at about $42 million.
Pacira Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.
Financials
| Company Type | Public - NASDAQ: PCRX Single Location |
|---|---|
| Fiscal Year-End | December |
| 2011 Employees | 133 |
Executives
23 executives listed for Pacira Pharmaceuticals, Inc.'s Parsippany, NJ location.
| Chairman | Frederick Middleton | |
|---|---|---|
| President, CEO, and Director | David Stack | |
| CFO | James Scibetta |